Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations

NCT05820152 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Due to the sponsor circumstances and external reasons

Conditions

Leber Hereditary Optic Neuropathy (LHON)

Interventions

DRUG: NFS-02 Injection

Sponsor

Neurophth Therapeutics Inc